ISMP (US) Contact Us Feedback

ISMP Canada News

March 8, 2017: Caution: M-Eslon Now Also Available as an Immediate-Release Product

For over 2 decades, healthcare practitioners have associated the name M-Eslon with an extended-release formulation of morphine. With the introduction of M-Eslon IR, an immediate-release morphine product, that association may present a danger to patients. The shared name was reported to ISMP Canada as a medication safety concern. There is a potential for a mix-up between the 2 products, especially since both M-Eslon and M-Eslon IR are available in 10 mg and 30 mg strengths. Furthermore, both products are available in capsule form, although the capsule colours differ between formulations of the overlapping strengths.  Read more ...